---
layout: default
title: TrialMatchAI: An End-to-End AI-powered Clinical Trial Recommendation System to Streamline Patient-to-Trial Matching
---

# TrialMatchAI: An End-to-End AI-powered Clinical Trial Recommendation System to Streamline Patient-to-Trial Matching

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2505.08508" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2505.08508v1</a>
  <a href="https://arxiv.org/pdf/2505.08508.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2505.08508v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2505.08508v1', 'TrialMatchAI: An End-to-End AI-powered Clinical Trial Recommendation System to Streamline Patient-to-Trial Matching')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Majd Abdallah, Sigve Nakken, Mariska Bierkens, Johanna Galvis, Alexis Groppi, Slim Karkar, Lana Meiqari, Maria Alexandra Rujano, Steve Canham, Rodrigo Dienstmann, Remond Fijneman, Eivind Hovig, Gerrit Meijer, Macha Nikolski

**åˆ†ç±»**: cs.AI, cs.LG, q-bio.QM

**å‘å¸ƒæ—¥æœŸ**: 2025-05-13

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºTrialMatchAIä»¥è§£å†³ä¸´åºŠè¯•éªŒæ‚£è€…åŒ¹é…é—®é¢˜**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `ä¸´åºŠè¯•éªŒ` `æ‚£è€…åŒ¹é…` `äººå·¥æ™ºèƒ½` `æ¨èç³»ç»Ÿ` `ç”Ÿç‰©åŒ»å­¦æ•°æ®` `ç²¾å‡†åŒ»ç–—` `è¯­è¨€æ¨¡å‹` `è‡ªåŠ¨åŒ–`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ‚£è€…æ‹›å‹Ÿåœ¨ä¸´åºŠè¯•éªŒä¸­æ•ˆç‡ä½ä¸‹ï¼Œç°æœ‰æ–¹æ³•éš¾ä»¥å¤„ç†å¼‚æ„æ•°æ®ï¼Œå¯¼è‡´åŒ¹é…æ•ˆæœä¸ä½³ã€‚
2. TrialMatchAIé€šè¿‡å¤„ç†å¤šç§ä¸´åºŠæ•°æ®ï¼Œåˆ©ç”¨å¾®è°ƒçš„LLMså’Œå¢å¼ºæ£€ç´¢ç”Ÿæˆæ¡†æ¶ï¼Œå®ç°æ‚£è€…ä¸è¯•éªŒçš„è‡ªåŠ¨åŒ¹é…ã€‚
3. åœ¨å®é™…åº”ç”¨ä¸­ï¼Œ92%çš„è‚¿ç˜¤æ‚£è€…åœ¨æ¨èä¸­æ‰¾åˆ°äº†ç›¸å…³è¯•éªŒï¼Œå‡†ç¡®ç‡è¶…è¿‡90%ï¼Œæ˜¾ç¤ºå‡ºæ˜¾è‘—çš„æ€§èƒ½æå‡ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

æ‚£è€…æ‹›å‹Ÿåœ¨ä¸´åºŠè¯•éªŒä¸­ä»ç„¶æ˜¯ä¸€ä¸ªä¸»è¦ç“¶é¢ˆï¼Œæ€¥éœ€å¯æ‰©å±•çš„è‡ªåŠ¨åŒ–è§£å†³æ–¹æ¡ˆã€‚æœ¬æ–‡æå‡ºäº†TrialMatchAIï¼Œä¸€ä¸ªåŸºäºAIçš„æ¨èç³»ç»Ÿï¼Œé€šè¿‡å¤„ç†å¼‚æ„ä¸´åºŠæ•°æ®ï¼ˆåŒ…æ‹¬ç»“æ„åŒ–è®°å½•å’Œéç»“æ„åŒ–åŒ»ç”Ÿç¬”è®°ï¼‰æ¥è‡ªåŠ¨åŒ–æ‚£è€…ä¸è¯•éªŒçš„åŒ¹é…ã€‚è¯¥ç³»ç»ŸåŸºäºå¾®è°ƒçš„å¼€æºå¤§å‹è¯­è¨€æ¨¡å‹ï¼ˆLLMsï¼‰ï¼Œåœ¨å¢å¼ºæ£€ç´¢ç”Ÿæˆæ¡†æ¶å†…æ„å»ºï¼Œç¡®ä¿é€æ˜æ€§å’Œå¯é‡å¤æ€§ï¼Œå¹¶ä¿æŒé€‚åˆä¸´åºŠç¯å¢ƒçš„è½»é‡çº§éƒ¨ç½²ã€‚ç³»ç»Ÿé€šè¿‡æ ‡å‡†åŒ–ç”Ÿç‰©åŒ»å­¦å®ä½“ï¼Œç»“åˆè¯æ±‡å’Œè¯­ä¹‰ç›¸ä¼¼æ€§çš„æ··åˆæœç´¢ç­–ç•¥æ£€ç´¢ç›¸å…³è¯•éªŒï¼Œé‡æ–°æ’åºç»“æœï¼Œå¹¶ä½¿ç”¨åŒ»å­¦æ¨ç†è¿›è¡Œæ ‡å‡†çº§åˆ«çš„èµ„æ ¼è¯„ä¼°ã€‚å®é™…éªŒè¯ä¸­ï¼Œ92%çš„è‚¿ç˜¤æ‚£è€…åœ¨å‰20ä¸ªæ¨èä¸­è‡³å°‘æ‰¾åˆ°äº†ä¸€ä¸ªç›¸å…³è¯•éªŒã€‚è¯„ä¼°ç»“æœæ˜¾ç¤ºï¼Œè¯¥ç³»ç»Ÿåœ¨åˆæˆå’ŒçœŸå®ä¸´åºŠæ•°æ®é›†ä¸Šè¡¨ç°å‡ºè‰²ï¼Œä¸“å®¶è¯„ä¼°ç¡®è®¤æ ‡å‡†çº§åˆ«èµ„æ ¼åˆ†ç±»çš„å‡†ç¡®ç‡è¶…è¿‡90%ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæœ¬æ–‡æ—¨åœ¨è§£å†³ä¸´åºŠè¯•éªŒä¸­æ‚£è€…æ‹›å‹Ÿçš„ä½æ•ˆç‡é—®é¢˜ï¼Œç°æœ‰æ–¹æ³•éš¾ä»¥æœ‰æ•ˆå¤„ç†å¼‚æ„æ•°æ®ï¼Œå¯¼è‡´æ‚£è€…ä¸è¯•éªŒçš„åŒ¹é…æ•ˆæœä¸ç†æƒ³ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šTrialMatchAIçš„æ ¸å¿ƒæ€è·¯æ˜¯é€šè¿‡è‡ªåŠ¨åŒ–å¤„ç†å¤šç§ç±»å‹çš„ä¸´åºŠæ•°æ®ï¼Œç»“åˆå…ˆè¿›çš„è¯­è¨€æ¨¡å‹å’Œæ£€ç´¢æŠ€æœ¯ï¼Œå®ç°é«˜æ•ˆçš„æ‚£è€…ä¸è¯•éªŒåŒ¹é…ã€‚è¿™æ ·çš„è®¾è®¡æ—¨åœ¨æé«˜åŒ¹é…çš„å‡†ç¡®æ€§å’Œæ•ˆç‡ï¼ŒåŒæ—¶ç¡®ä¿ç»“æœçš„å¯è§£é‡Šæ€§ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šè¯¥ç³»ç»Ÿçš„æ•´ä½“æ¶æ„åŒ…æ‹¬æ•°æ®æ ‡å‡†åŒ–ã€æ··åˆæœç´¢ç­–ç•¥ã€ç»“æœé‡æ–°æ’åºå’Œèµ„æ ¼è¯„ä¼°å››ä¸ªä¸»è¦æ¨¡å—ã€‚é¦–å…ˆï¼Œç³»ç»Ÿå¯¹ç”Ÿç‰©åŒ»å­¦å®ä½“è¿›è¡Œæ ‡å‡†åŒ–ï¼Œç„¶åé€šè¿‡è¯æ±‡å’Œè¯­ä¹‰ç›¸ä¼¼æ€§æ£€ç´¢ç›¸å…³è¯•éªŒï¼Œæ¥ç€å¯¹ç»“æœè¿›è¡Œé‡æ–°æ’åºï¼Œæœ€åè¿›è¡Œèµ„æ ¼è¯„ä¼°ã€‚

**å…³é”®åˆ›æ–°**ï¼šTrialMatchAIçš„å…³é”®åˆ›æ–°åœ¨äºå…¶ç»“åˆäº†å¾®è°ƒçš„å¼€æºLLMsä¸å¢å¼ºæ£€ç´¢ç”Ÿæˆæ¡†æ¶ï¼Œç¡®ä¿äº†ç³»ç»Ÿçš„é€æ˜æ€§å’Œå¯é‡å¤æ€§ï¼ŒåŒæ—¶æ”¯æŒè½»é‡çº§çš„ä¸´åºŠç¯å¢ƒéƒ¨ç½²ã€‚è¿™ä¸ä¼ ç»Ÿæ–¹æ³•ç›¸æ¯”ï¼Œæ˜¾è‘—æå‡äº†åŒ¹é…çš„å‡†ç¡®æ€§å’Œæ•ˆç‡ã€‚

**å…³é”®è®¾è®¡**ï¼šç³»ç»Ÿè®¾è®¡ä¸­é‡‡ç”¨äº†æ ‡å‡†åŒ–çš„Phenopacketsæ•°æ®æ ¼å¼ï¼Œæ”¯æŒå®‰å…¨çš„æœ¬åœ°éƒ¨ç½²ï¼Œå¹¶å…è®¸éšç€æ–°æ¨¡å‹çš„å‡ºç°æ— ç¼æ›¿æ¢LLMç»„ä»¶ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

åœ¨å®é™…éªŒè¯ä¸­ï¼ŒTrialMatchAIæˆåŠŸåœ°ä¸º92%çš„è‚¿ç˜¤æ‚£è€…åœ¨å‰20ä¸ªæ¨èä¸­æ‰¾åˆ°äº†è‡³å°‘ä¸€ä¸ªç›¸å…³è¯•éªŒï¼Œä¸”åœ¨æ ‡å‡†çº§åˆ«èµ„æ ¼åˆ†ç±»çš„å‡†ç¡®ç‡è¶…è¿‡90%ã€‚è¿™äº›ç»“æœè¡¨æ˜ï¼Œè¯¥ç³»ç»Ÿåœ¨æ‚£è€…åŒ¹é…æ–¹é¢çš„æ˜¾è‘—æ€§èƒ½æå‡ï¼Œå°¤å…¶æ˜¯åœ¨ç”Ÿç‰©æ ‡å¿—ç‰©é©±åŠ¨çš„åŒ¹é…ä¸­è¡¨ç°ä¼˜å¼‚ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

TrialMatchAIåœ¨ç²¾å‡†åŒ»ç–—é¢†åŸŸå…·æœ‰å¹¿æ³›çš„åº”ç”¨æ½œåŠ›ï¼Œèƒ½å¤Ÿæœ‰æ•ˆæå‡ä¸´åºŠè¯•éªŒçš„æ‚£è€…æ‹›å‹Ÿæ•ˆç‡ï¼Œå¸®åŠ©åŒ»ç”Ÿå’Œç ”ç©¶äººå‘˜å¿«é€Ÿæ‰¾åˆ°åˆé€‚çš„è¯•éªŒï¼Œä»è€ŒåŠ é€Ÿæ–°ç–—æ³•çš„å¼€å‘å’Œåº”ç”¨ã€‚æœªæ¥ï¼Œè¯¥ç³»ç»Ÿå¯æ‰©å±•è‡³å…¶ä»–åŒ»ç–—é¢†åŸŸï¼Œæ¨åŠ¨ä¸ªæ€§åŒ–åŒ»ç–—çš„è¿›æ­¥ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Patient recruitment remains a major bottleneck in clinical trials, calling for scalable and automated solutions. We present TrialMatchAI, an AI-powered recommendation system that automates patient-to-trial matching by processing heterogeneous clinical data, including structured records and unstructured physician notes. Built on fine-tuned, open-source large language models (LLMs) within a retrieval-augmented generation framework, TrialMatchAI ensures transparency and reproducibility and maintains a lightweight deployment footprint suitable for clinical environments. The system normalizes biomedical entities, retrieves relevant trials using a hybrid search strategy combining lexical and semantic similarity, re-ranks results, and performs criterion-level eligibility assessments using medical Chain-of-Thought reasoning. This pipeline delivers explainable outputs with traceable decision rationales. In real-world validation, 92 percent of oncology patients had at least one relevant trial retrieved within the top 20 recommendations. Evaluation across synthetic and real clinical datasets confirmed state-of-the-art performance, with expert assessment validating over 90 percent accuracy in criterion-level eligibility classification, particularly excelling in biomarker-driven matches. Designed for modularity and privacy, TrialMatchAI supports Phenopackets-standardized data, enables secure local deployment, and allows seamless replacement of LLM components as more advanced models emerge. By enhancing efficiency and interpretability and offering lightweight, open-source deployment, TrialMatchAI provides a scalable solution for AI-driven clinical trial matching in precision medicine.

